Minimal exposure intra-arterial chemotherapy for children with retinoblastoma and 13q syndrome

Two infants with retinoblastoma and 13q syndrome with multiorgan system anomalies were treated with targeted intra-arterial chemotherapy (IAC) using one-to-three cycles of melphalan 5 mg to avoid systemic chemotherapeutic side effects. Both patients showed good response, with tumor control and no sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Dillon, Alexander B., Douglass, Alexzandra, Jabbour, Pascal, Shields, Carol L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084500/
https://www.ncbi.nlm.nih.gov/pubmed/27843232
http://dx.doi.org/10.4103/0974-620X.192278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084500/
https://www.ncbi.nlm.nih.gov/pubmed/27843232
http://dx.doi.org/10.4103/0974-620X.192278

Ejemplares similares